Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 1/20 | 0.46 |
| ▸ | MCHR1 | Q99705 | 6/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HTR5A | P47898 | 3/20 | 0.38 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.38 |
| ▸ | HPGDS | O60760 | 1/20 | 0.38 |
| ▸ | PLK1 | P53350 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30489513 | 0.91 | CSF1R (0.43) | MCHR1HIF1AGRM5 | |
| SCHEMBL30489511 | 0.88 | MCHR1 (0.51) | MCHR1 | |
| SCHEMBL21999955 | 0.82 | HDAC1 (0.47) | MCHR1HPGDSESR2 | |
| SCHEMBL21588441 | 0.82 | ESR2 (0.45) | MCHR1BRD3HPGDSESR2 | |
| SCHEMBL25634076 | 0.81 | MCHR1 (0.50) | MCHR1HIF1AHTR5A | |
| SCHEMBL30489504 | 0.81 | S1PR2 (0.42) | S1PR2HTR5AHPGDSGRM5GRM1 | |
| SCHEMBL1003831 | 0.81 | USP30 (0.46) | MCHR1GRM5ESR2 | |
| SCHEMBL30489508 | 0.80 | MCHR1 (0.57) | MCHR1 | |
| SCHEMBL21588362 | 0.78 | KRAS (0.45) | BRD3HPGDSPLK1ESR2 | |
| SCHEMBL5108079 | 0.78 | BAZ2B (0.53) | HTR5AHPGDSPLK1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250235463-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. | 2025-07-24 | — | — | US | disclosed |
| US-12295959-B2 | Phenoxy and benzyloxy substituted psychoplastogens and uses thereof | DELIX THERAPEUTICS, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| EP-4448531-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | Delix Therapeutics, Inc. (US) | 2024-10-23 | — | — | EP | disclosed |
| US-20240335454-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. | 2024-10-10 | — | — | US | disclosed |
| WO-2023114313-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335454-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | GAP43, BDNF, GRIN2A | S1PR2 1460/4885MCHR1 633/4885HIF1A 2997/4885 |
| US-12295959-B2 | Phenoxy and benzyloxy substituted psychoplastogens and uses thereof | GAP43, BDNF, GRIN2A | S1PR2 1460/4885MCHR1 633/4885HIF1A 2997/4885 |
| US-20250235463-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | GAP43, BDNF, GRIN2A | S1PR2 1460/4885MCHR1 633/4885HIF1A 2997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.